ストックスクリーナーアプリを入手
90.45
0.39%
-1.03
前日終値:
$91.48
開ける：
$91.96
24時間の取引高:
964.27K
Relative Volume:
0.17
時価総額：
$34.16B
収益：
$4.82B
当期純損益:
$930.40M
株価収益率:
38.69
EPS:
2.3381
ネットキャッシュフロー:
$1.43B
1週間 パフォーマンス:
+7.52%
1か月 パフォーマンス:
+22.94%
6か月 パフォーマンス:
+30.14%
1年 パフォーマンス:
+13.96%
1日の値動き範囲:
$90.45
$91.96
1週間の範囲:
$84.53
$91.96
52週間の値動き範囲:
$54.11
$91.96
Dexcom Inc Stock (DXCM) Company Profile
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
90.51 | 34.26B | 4.82B | 930.40M | 1.43B | 2.3381 |
ABT
Abbott Laboratories
|
111.83 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
340.48 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.82 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
52.55 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.01 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-24 | アップグレード | Evercore ISI | In-line → Outperform |
| 2026-01-12 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2025-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 開始されました | Evercore ISI | In-line |
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 開始されました | Argus | Buy |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-02-03 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 開始されました | Redburn Atlantic | Neutral |
| 2024-03-12 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-04-17 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2023-01-26 | 開始されました | Wolfe Research | Outperform |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-15 | 開始されました | Bernstein | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-10-18 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-28 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2021-01-06 | アップグレード | UBS | Neutral → Buy |
| 2020-10-02 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 繰り返されました | Piper Sandler | Overweight |
| 2020-05-14 | 開始されました | Wells Fargo | Equal Weight |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-11-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-10-23 | 開始されました | Stifel | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-19 | アップグレード | Goldman | Sell → Neutral |
| 2018-09-12 | アップグレード | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-07-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 開始されました | BofA/Merrill | Buy |
| 2018-05-03 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-04-04 | 開始されました | Goldman | Sell |
| 2018-04-04 | 開始されました | Guggenheim | Neutral |
| 2018-03-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | ダウングレード | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 繰り返されました | Wedbush | Outperform |
すべてを表示
Dexcom Inc (DXCM) 最新ニュース
Dexcom (DXCM) director Augustinos donates 1,075 shares and reports 5,575 RSUs - stocktitan.net
DexCom Inc (MIL:1DXCM) Stock Price, Trades & News - GuruFocus
Dexcom stock holds above $90 as strong Q2 2026 margins support a raised outlook - AD HOC NEWS
Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago - finance.yahoo.com
Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating - marketscreener.com
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches? - TradingView
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here? - TradingView
DexCom (DXCM) director Bridgette Heller sells 1,012 shares in planned trade - stocktitan.net
E. Ohman J or Asset Management AB Has $7.62 Million Position in DexCom, Inc. $DXCM - marketbeat.com
Dexcom Inc (DXCM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stronger Q2 Results and Higher 2026 Outlook Might Change The Case For Investing In DexCom (DXCM) - simplywall.st
DexCom stock hits 52-week high at 87.85 USD By Investing.com - Investing.com UK
DexCom Inc (DXCM) Stock Up 3.4% and Still Undervalued -- GF Scor - GuruFocus
DexCom (NASDAQ:DXCM) Reaches New 1-Year HighWhat's Next? - marketbeat.com
DexCom stock hits 52-week high at 87.85 USD - Investing.com
DexCom, Inc. (DXCM) Stock Analysis: Exploring The 10.25% Potential Upside For Investors - DirectorsTalk Interviews
Assenagon Asset Management S.A. Has $46.72 Million Holdings in DexCom, Inc. $DXCM - marketbeat.com
DexCom, Inc. $DXCM Stock Position Lifted by Gradient Investments LLC - marketbeat.com
DexCom, Inc. $DXCM Shares Sold by Pacer Advisors Inc. - marketbeat.com
Beacon Investment Advisory Services Inc. Reduces Stake in DexCom, Inc. $DXCM - marketbeat.com
Dexcom Inc (DXCM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DXCM|Dexcom Inc|Price:84.750|Chg%:+1.730 - TradingKey
DexCom Inc. Stock Sheds 4.9%, Underperforms Market - webull.com
DexCom, Inc. (NASDAQ:DXCM) Given Consensus Rating of "Moderate Buy" by Brokerages - marketbeat.com
DexCom Inc (DXCM) Shares Fall 4.9% -- What GF Score of 94 Tells Investors - GuruFocus
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DexCom, Inc. (DXCM) Stock Forecasts - Yahoo! Finance Canada
Rathbones Group PLC Reduces Holdings in DexCom, Inc. $DXCM - MarketBeat
Edgestream Partners L.P. Has $981,000 Holdings in DexCom, Inc. $DXCM - marketbeat.com
DexCom, Inc. (DXCM) Stock forecasts - Yahoo Finance Singapore
DexCom (NASDAQ:DXCM) Director Mark Foletta Sells 2,000 Shares - marketbeat.com
DexCom Inc (DXCM) director’s family trust sells 4,000 shares under 10b5-1 plan - stocktitan.net
Class Action Alert: Levi & Korsinsky Reminds DexCom (DXCM) Investors of December 26, 2025 Deadline - The National Law Review
Levi & Korsinsky Urges DexCom (DXCM) Shareholders to Act Before Lead Plaintiff Deadline December 26, 2025 - The National Law Review
Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating - marketscreener.com
DEXCOM INC : ARGUS RESEARCH RAISES TARGET PRICE BY $10 TO $96 - Bitget
Dexcom Inc : Argus Research Raises Target Pri - Moomoo
DexCom (NASDAQ:DXCM) Stands Out as an Affordable Growth Stock - ChartMill
DexCom Inc (DXCM) Stock Up 4.6% and Still Undervalued -- GF Scor - GuruFocus
Levi & Korsinsky Notifies DexCom, Inc. (DXCM) Shareholders of Cla - The National Law Review
Insider Selling: DexCom (NASDAQ:DXCM) Director Sells 2,000 Shares - MarketBeat
Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day - The National Law Review
DexCom (DXCM) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance
DexCom (DXCM) Is Up 16.6% After Raising 2026 Revenue Guidance And Margin OutlookHas The Bull Case Changed? - webull.com
DexCom, Inc. (DXCM) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
DexCom: Still A Cautious Buy Following Earnings (NASDAQ:DXCM) - Seeking Alpha
DexCom, Inc. (DXCM) Stock Analysis: Strong Analyst Ratings and Promising 11.20% Potential Upside - DirectorsTalk Interviews
DexCom (DXCM) Stock Sees Fair Value Lift After Analyst Target Increases - finance.yahoo.com
DexCom Inc. Stock Rises 12.0%, Outperforms Peers - webull.com
Dexcom Inc (DXCM) 財務データ
収益
当期純利益
現金流量
EPS
0.01%
0.74%
大文字化:
|
ボリューム (24 時間):